NCI-H3122 - Wikidata
Jump to content
- Item
- Discussion
- Read
- View history
- Read
- View history
- What links here
- Related changes
- Permanent link
- Page information
- Cite this page
- Get shortened URL
- Download QR code
- Concept URI
- Create a book
- Download as PDF
- Printable version
- H3122
- H-3122
- NCIH3122
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined | ||
| English | NCI-H3122 | cell line |
|
Statements
instance of cell line 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 cancer cell line 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 described by source Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 Sensitivity of non-small-cell lung cancer cell lines established from patients treated with prolonged infusions of Paclitaxel 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 Lung Cancer Cell Lines as Tools for Biomedical Discovery and Research 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1. 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 Heterogeneity of genetic changes associated with acquired crizotinib resistance in ALK-rearranged lung cancer. 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non-Small Cell Lung Cancer 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 Comparative proteome analysis across non-small cell lung cancer cell lines 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 A landscape of pharmacogenomic interactions in cancer. 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 Differential Effector Engagement by Oncogenic KRAS. 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 Next-generation characterization of the Cancer Cell Line Encyclopedia 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer. 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 From clinical specimens to human cancer preclinical models-a journey the NCI-cell line database-25 years later 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 established from medical condition adenocarcinoma of the lung 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 derived from organism type Homo sapiens sex or gender male 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 exact match http://purl.obolibrary.org/obo/CLO_0037033 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160Identifiers
Cell Line Ontology ID CLO_0037033 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160 Cellosaurus ID CVCL_5160 1 reference stated in Cellosaurus release 49 retrieved 14 July 2024 Cellosaurus ID CVCL_5160Sitelinks
Wikipedia(0 entries)
editWikibooks(0 entries)
editWikinews(0 entries)
editWikiquote(0 entries)
editWikisource(0 entries)
editWikiversity(0 entries)
editWikivoyage(0 entries)
editWiktionary(0 entries)
editMultilingual sites(0 entries)
edit Retrieved from "https://www.wikidata.org/w/index.php?title=Q54908028&oldid=2258428787" Search Search NCI-H3122 (Q54908028) Add topicTừ khóa » H3122
-
Cellosaurus Cell Line NCI-H3122 (CVCL_5160) - Expasy
-
Cellosaurus Cell Line NCI-H3122-CR1 (CVCL_AY53) - Expasy
-
Hypoxia Induces Resistance To ALK Inhibitors In The H3122 Non ...
-
NCI-H3122: Human Lung Adenocarcinoma
-
Models For Non-small Cell Lung Carcinoma - Part 2
-
NCIH3122 DepMap Cell Line Summary
-
Morphologic Change And Migration Of The H3122 Cell Line. (A)...
-
H 3122 - Adapter Sleeves For Metric Shafts - SKF
-
Cellonco™ Human NCI-H3122 Tumor Cell Line - Creative Biolabs
-
Therapeutic Strategies To Overcome Crizotinib Resistance In ... - PNAS
-
P-glycoprotein Confers Acquired Resistance To 17-DMAG In Lung ...
-
EMT Is Associated With, But Does Not Drive Resistance To ALK ...
-
Bill H.3122 189th (2015 - 2016) - Massachusetts Legislature